© 2016 All rights reserved.
Specialty-specific health information technology leader, Modernizing Medicine, Inc., today announced it has joined Xcertia™, a collaborative dedicated to improving the quality, safety and effectiveness of mobile health applications, or apps.more»
Statistically significant results confirm the mechanism of action of AltemiaTM for the treatment of SCDmore»
Cancer Treatment Centers of America® (CTCA), a national network of five hospitals headquartered in Boca Raton, Fla., ranked third in the US Hospitals category of YouGov’s 2017 Brand Health rankings.more»
The Nova Southeastern University (NSU) College of Allopathic Medicine has received preliminary accreditation - a major milestone that allows the new medical school to accept an inaugural class of 50 students into its innovative and coveted Doctor of Medicine (M.D.) program, which will matriculate in August 2018.more»
Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced the successful completion of a randomized, double blinded, placebo controlled clinical trial in pediatric sickle cell patients aged 5 – 17 years old. The clinical trial is a multi-center study designed to evaluate treatment effects and safety of AltemiaTM, a novel pharmaceutical preparation utilizing the Company’s Advanced Lipid Technologies (ALT®) platform.more»
The 2017 BioFlorida Annual Conference is taking place October 15-17 at The Vinoy Renaissance in St. Petersburg, FL. Please register today and join us as we recognize 20 years of advancing the life sciences in Florida.more»